The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide

CAN WANG24 enrolled

Overview

Based on the study about carbon monoxide in human inflammatory and other beneficial physiological function , now we'll be going to research its application in neonates .Phase 1 Study as a foundation for the further test is, the safety and Adverse reaction study of newborn to inhaled CO

Previous studies have demonstrated that, carbon monoxide has showed the effectiveness such as in inflammation ,apoptosis as well as relaxation of smooth muscle of the body. Now we have a hypothesis to use carbon monoxide in pulmonary hypertension of the newborns, to observe whether it will decrease pulmonary artery hypertension on newborns. Phase 1 study is ,the safety and Adverse reaction study of newborn to inhaled CO , after this,we can master the application of carbon monoxide dose

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Miscellaneous Disorders in the Fetus or Newborn

Interventions

Inhaled Carbon MonoxideOTHER

Inhaled Carbon Monoxide in newborn

Eligibility

Sex: ALLMin age: 1 MinuteMax age: 1 MonthHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * The newborn whose physiological function is healthy or close to healthy Exclusion Criteria: * Clinical considerations cannot survive or no treatment value of newborn Diagnosis of congenital or hereditary diseases, or children with heart diseaseCentral pulmonary vascular malformations in children

Locations (1)

Daping Hospital

Chongqing, Chongqing Municipality, China

Outcomes

Primary Outcomes

Number of participants with adverse events

Time frame: up to 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.